Norbert Schmitz
Impact in
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment
- Hematology top 0.05%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 251
- Hematology 185
- Hematopoietic Stem Cell Transplantation 101
- Acute Myeloid Leukemia Research 68
- Chronic Myeloid Leukemia Treatments 50
- Co-authors
- Peter Dreger (88 shared papers)Michael G. Pfreundschuh (59 shared papers)Markus W. Loeffler (34 shared papers)Bertram A. Glass (38 shared papers)Marita Ziepert (44 shared papers)David C. Linch (10 shared papers)Anthony H. Goldstone (12 shared papers)Anna Sureda (44 shared papers)
- Journals
- Blood (142 papers)Journal of Clinical Oncology (39 papers)British Journal of Haematology (32 papers)Bone Marrow Transplantation (32 papers)Annals of Oncology (24 papers)
- Partner nations
- GermanyUnited KingdomFrance
In The Last Decade
Norbert Schmitz
460 papers receiving 25.6k citations
Norbert Schmitz's Hit Papers
Peers
Comparison fields: 5 of 131
- Pathology and Forensic Medicine 14.3k
- Hematology 8.0k
- Genetics 6.5k
- Oncology 9.6k
- Neurology 4.0k
Countries citing papers authored by Norbert Schmitz
This map shows the geographic impact of Norbert Schmitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Schmitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Schmitz more than expected).
Fields of papers citing papers by Norbert Schmitz
This network shows the impact of papers produced by Norbert Schmitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Schmitz. The network helps show where Norbert Schmitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Norbert Schmitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 474 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era Hit paper breakdown → | 2010 | 1349 |
| 2 | Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Hit paper breakdown → | 2013 | 1262 |
| 3 | Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) Hit paper breakdown → | 2008 | 925 |
| 4 | Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial Hit paper breakdown → | 2002 | 905 |
| 5 | 1996 | 510 | |
| 6 | Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20 + B-Cell Lymphoma in the Rituximab Era Hit paper breakdown → | 2010 | 479 |
| 7 | 2010 | 451 | |
| 8 | MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma Hit paper breakdown → | 2013 | 446 |
| 9 | 2000 | 433 | |
| 10 | 1995 | 406 | |
| 11 | 2008 | 342 | |
| 12 | CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP Hit paper breakdown → | 2016 | 338 |
| 13 | 2002 | 319 | |
| 14 | A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis Hit paper breakdown → | 2016 | 315 |
| 15 | 2016 | 308 | |
| 16 | 2017 | 270 | |
| 17 | 2003 | 263 | |
| 18 | 2007 | 262 | |
| 19 | 1994 | 256 | |
| 20 | 2009 | 248 |
About Norbert Schmitz
Norbert Schmitz is a scholar working on Pathology and Forensic Medicine, Hematology, Genetics, Oncology and Immunology, having authored 474 papers that have together received 26.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (251 papers), Chronic Lymphocytic Leukemia Research (124 papers), Hematopoietic Stem Cell Transplantation (101 papers), Acute Myeloid Leukemia Research (68 papers), Viral-associated cancers and disorders (58 papers), CAR-T cell therapy research (57 papers), Acute Lymphoblastic Leukemia research (55 papers) and Chronic Myeloid Leukemia Treatments (50 papers). The work is most often cited by research in Pathology and Forensic Medicine (14.3k citations), Hematology (8.0k citations), Genetics (6.5k citations), Oncology (9.6k citations) and Neurology (4.0k citations). Norbert Schmitz has collaborated with scholars based in Germany, United Kingdom and France. Frequent co-authors include Peter Dreger, Michael G. Pfreundschuh, Markus W. Loeffler, Bertram A. Glass, Marita Ziepert, David C. Linch, Anthony H. Goldstone, Anna Sureda, Alois A. Gratwohl and Samira Zeynalova. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Bone Marrow Transplantation and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.